Drug

Who makes cladribine?

7 companies list cladribine as a human prescription drug, including under the names Mavenclad. Forms: injection; injection, solution; tablet. Routes: intravenous, oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing cladribine

CompanyFormsApplicationNDCsRegistered sites
EMD Serono, Inc.FrancetabletNDANDA022561112
Apotex Inc.CanadatabletANDAANDA21842516
Fresenius Kabi USA, LLCUnited StatesinjectionANDAANDA07657116
Sandoz Industrial Products S.AAustriatabletANDAANDA21554715
Hikma Pharmaceuticals USA Inc.United StatesinjectionANDAANDA07540514
Genvion CorporationCanadatabletANDAANDA21842511
Hisun Pharmaceuticals USA, Inc.injection, solutionANDAANDA21085610

Bulk ingredient listings

Orange Book patents

3 unexpired patents list cladribine as the active ingredient, expiring between Nov 2038 and Sept 2041. Application holder: EMD SERONO INC.

Enquiry

Common questions

Who makes cladribine?
7 companies list cladribine as a human prescription drug in the openFDA NDC Directory, led by EMD Serono, Inc., Apotex Inc., Fresenius Kabi USA, LLC, Sandoz Industrial Products S.A, Hikma Pharmaceuticals USA Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic Mavenclad?
6 companies list cladribine under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies cladribine active ingredient?
6 companies list cladribine as a bulk ingredient, including Cilag AG, Sionc Pharmaceuticals Private Limited, MSN Laboratories Private Limited,, Reliable Biopharmaceutical, LLC.